On May 13, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) published the decisions, in which they recommended the transfer to standard care for three completed projects. The projects relate to healthcare coordination, polypharmacy, and neonatal screening.
A short overview of the projects is provided below:
- "CoCare (coordinated medical care) – Extended coordinated medical nursing home care" project aimed to improve coordinated medical nursing home care and optimize the interactions between nursing staff and doctors within the healthcare system to reduce avoidable hospital admissions and patient transportation. The proposed actions to achieve this goal included joint general practitioner and specialist doctor visits of doctors and nursing home coordinators, the formation of medical teams, a joint electronic patient file, joint training courses, and extended availability of medical care;
- "EVITA - Evidence-based polypharmacy program with implementation in healthcare practice" project aimed to develop a comprehensive, effective, and cost-effective care program for patients taking multiple medications. The project results provide detailed indications of future needs-based care in everyday life. In addition, more far-reaching solutions were designed in the project for optimized care of patients who have complex needs due to multimorbidity and the need to take multiple medications;
- "INSIST - Impact of neonatal screening on infection prediction/reduction of transmission" project researched whether and how the screening can help to improve the care of premature babies and prevent outbreaks of infections.
Innovation Fund is a vital instrument to propose and test a novel model of care (including the ones in the form of selective contracts). If the model proves valuable, it can be a subject for further dissemination in the country.
The detailed results of the projects are now being forwarded to the relevant organizations and institutions in the healthcare sector. In this regard, the respective stakeholders are requested to review the results and to consider them within their area of responsibility as far as possible.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.